Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Willingboro › NPI 1053316844
Hospital

Virtua Willingboro Hospital INC

Virtua Willingboro Hospital INC was paid $48.23M by Medicaid between Jan 2018 and Dec 2024, across 240 billing codes. Its largest line is 99284, emergency room visit (serious) — 34% of everything it billed.

33Billing provider infoVIRTUA WILLINGBORO HOSPITAL INC
WILLINGBORO, NJ 08046
33aNPI1053316844assigned 06/17/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$48.23M
24GClaims834,444
24DCodes billed240
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#35 of 93
Median peer was paid$30.60M
This provider vs. median1.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018149,100$7.64M
2019117,556$5.91M
202073,022$4.50M
2021104,576$7.46M
2022132,829$8.68M
2023147,085$7.58M
2024incomplete110,276$6.46M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 34% 42,638 37,862 $16.19M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 28,859 26,597 $7.36M
G0378 Hospital observation service, per hour 7.6% 4,682 3,724 $3.67M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.8% 8,600 7,725 $3.28M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.9% 4,349 4,194 $929K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.9% 2,401 2,308 $916K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.8% 27,710 8,259 $857K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.7% 580 541 $833K
70450 Computed tomography, head or brain; without contrast material 1.5% 7,863 7,387 $722K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.5% 43,376 11,053 $714K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 3,780 3,592 $620K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.3% 4,181 4,042 $613K
228 more codes
OP272 <1% 5,352 $477K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 19,631 $446K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 19,828 $437K
OP370 <1% 3,218 $393K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,722 $367K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,794 $350K
71045 Radiologic examination, chest; single view <1% 12,145 $330K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,928 $322K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,950 $320K
71046 Radiologic examination, chest; 2 views <1% 7,814 $308K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 5,287 $246K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 37,090 $234K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 7,440 $215K
72125 Computed tomography, cervical spine; without contrast material <1% 1,686 $200K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 8,447 $197K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,571 $197K
80048 Basic metabolic panel (calcium, ionized) <1% 40,258 $196K
76830 Ultrasound, transvaginal <1% 1,325 $190K
OP259 <1% 45,004 $181K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 238 $179K
96375 Therapeutic injection; each additional sequential IV push <1% 3,901 $177K
73562 <1% 2,168 $175K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,868 $155K
73030 <1% 2,710 $137K
97161 <1% 3,894 $137K
70551 Magnetic resonance imaging, brain; without contrast material <1% 277 $134K
73610 <1% 2,741 $131K
73564 <1% 2,431 $129K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,606 $125K
96361 Intravenous infusion, hydration; each additional hour <1% 4,274 $122K
73630 <1% 3,031 $121K
72110 <1% 1,356 $118K
OP710 <1% 1,670 $116K
95957 <1% 148 $115K
80076 <1% 27,347 $113K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,823 $113K
73130 <1% 2,629 $105K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 469 $104K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,124 $100K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 6,537 $97K
OP258 <1% 14,693 $97K
71250 <1% 697 $95K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,321 $91K
93017 <1% 382 $88K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 109 $88K
93971 <1% 864 $88K
84484 <1% 15,083 $87K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,092 $75K
97162 <1% 1,771 $73K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 895 $72K
80320 <1% 6,507 $69K
73502 <1% 1,701 $67K
83880 <1% 4,777 $66K
36415 Collection of venous blood by venipuncture <1% 33,454 $64K
73110 <1% 1,371 $62K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,928 $62K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 42 $59K
A9270 Non-covered item or service <1% 2,426 $56K
97164 <1% 1,514 $53K
95816 <1% 183 $53K
85730 <1% 14,550 $52K
0240U <1% 1,449 $52K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,648 $52K
85610 <1% 15,138 $49K
OP250 <1% 5,312 $48K
90715 <1% 2,008 $47K
80329 <1% 2,424 $39K
70486 <1% 320 $35K
84443 Thyroid stimulating hormone (TSH) <1% 4,264 $34K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 64 $34K
83605 <1% 3,403 $34K
72100 <1% 624 $32K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 92 $32K
87040 <1% 2,940 $31K
93970 <1% 215 $30K
83735 <1% 7,561 $30K
83690 <1% 10,867 $29K
73590 <1% 738 $29K
81001 <1% 14,521 $28K
85027 <1% 5,228 $26K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,824 $26K
80306 <1% 4,360 $26K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,634 $26K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 24 $23K
76536 <1% 172 $23K
70496 <1% 136 $22K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,620 $22K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,017 $22K
87070 <1% 3,151 $20K
J1644 Injection, heparin sodium, per 1000 units <1% 2,775 $20K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,634 $20K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,572 $20K
J2704 Injection, propofol, 10 mg <1% 3,729 $19K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 13 $19K
76801 <1% 336 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,903 $18K
77080 <1% 342 $18K
70498 <1% 123 $18K
94664 <1% 2,330 $18K
96376 <1% 794 $17K
88342 <1% 382 $16K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,638 $16K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 307 $16K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 118 $15K
86900 <1% 1,624 $14K
87430 <1% 2,928 $14K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 339 $13K
80053 Comprehensive metabolic panel <1% 1,560 $13K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,912 $13K
96367 <1% 284 $13K
80061 Lipid panel <1% 1,638 $13K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,482 $13K
J2785 Injection, regadenoson, 0.1 mg <1% 52 $12K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,998 $12K
72050 <1% 152 $12K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,035 $12K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,268 $11K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $11K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 180 $11K
81003 <1% 5,687 $11K
73080 <1% 258 $10K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,438 $10K
74018 <1% 263 $9K
82550 <1% 3,251 $9K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 82 $9K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 42 $9K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 182 $9K
J2060 Injection, lorazepam, 2 mg <1% 2,099 $8K
85379 <1% 2,572 $8K
J3370 Injection, vancomycin hcl, 500 mg <1% 268 $8K
84702 <1% 1,315 $7K
86901 <1% 1,639 $7K
82962 <1% 6,203 $7K
A9585 Injection, gadobutrol, 0.1 ml <1% 269 $7K
85007 <1% 1,536 $7K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,490 $7K
J0690 Injection, cefazolin sodium, 500 mg <1% 917 $7K
87186 <1% 1,379 $7K
87077 <1% 1,432 $7K
86850 <1% 783 $7K
74022 <1% 168 $6K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,030 $6K
84100 <1% 1,821 $6K
OP229 <1% 121 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 848 $6K
97535 Self-care/home management training, each 15 minutes <1% 300 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 1,422 $5K
93976 <1% 66 $5K
J3490 Unclassified drugs <1% 17,457 $5K
76642 <1% 47 $5K
C9113 Injection, pantoprazole sodium, per vial <1% 341 $5K
73090 <1% 164 $5K
84703 <1% 1,980 $5K
87088 <1% 1,302 $5K
94760 <1% 2,536 $4K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 206 $4K
82803 <1% 99 $4K
J1630 Injection, haloperidol, up to 5 mg <1% 828 $4K
82150 <1% 418 $4K
86885 <1% 322 $4K
86140 <1% 1,647 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 492 $3K
86403 <1% 495 $3K
J1650 Injection, enoxaparin sodium, 10 mg <1% 901 $3K
J3475 Injection, magnesium sulfate, per 500 mg <1% 303 $3K
85378 <1% 422 $2K
87631 <1% 51 $2K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 1,824 $2K
80164 <1% 214 $2K
77066 Tomosynthesis, mammo <1% 12 $2K
84439 <1% 252 $2K
J1940 Injection, furosemide, up to 20 mg <1% 19 $2K
12001 <1% 13 $2K
72040 <1% 18 $2K
29125 <1% 13 $2K
74174 <1% 13 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,020 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,008 $2K
12011 <1% 12 $2K
88313 <1% 55 $1K
73140 <1% 67 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 229 $1K
J1815 Injection, insulin, per 5 units <1% 637 $1K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 39 $1K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 93 $964.31
76641 <1% 12 $958.35
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 64 $936.25
73552 <1% 57 $905.66
36591 <1% 215 $846.41
82607 <1% 132 $812.96
82728 <1% 118 $805.33
J3480 Injection, potassium chloride, per 2 meq <1% 48 $799.31
72070 <1% 25 $780.57
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 28 $775.39
71101 <1% 25 $739.02
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 39 $615.33
97163 <1% 12 $510.65
93356 <1% 14 $481.89
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 27 $435.56
73060 <1% 14 $427.42
85651 <1% 179 $418.40
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 161 $417.33
85652 <1% 587 $412.71
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 69 $352.74
OP637 <1% 371 $335.89
82746 <1% 60 $322.83
J1956 Injection, levofloxacin, 250 mg <1% 12 $310.39
97116 <1% 54 $291.77
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf <1% 25 $255.09
88304 <1% 12 $254.20
J0780 Injection, prochlorperazine, up to 10 mg <1% 61 $250.96
99001 <1% 73 $234.87
95851 <1% 46 $215.08
J1171 Injection, hydromorphone, 0.1 mg <1% 96 $211.02
J7050 Infusion, normal saline solution, 250 cc <1% 47 $161.04
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 268 $133.12
J3411 Injection, thiamine hcl, 100 mg <1% 14 $118.37
97165 <1% 26 $109.89
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 15 $100.38
83550 <1% 30 $97.11
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 496 $91.42
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 12 $56.14
82248 <1% 18 $37.35
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 14 $36.10
87081 <1% 16 $36.00
81025 <1% 19 $26.79
J7510 Prednisolone oral, per 5 mg <1% 13 $15.60
J7643 Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram <1% 65 $4.94

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKIRBY, JOHN (PRESIDENT VIRTUA WILLINGBORO HOSP)
Parent organizationVIRTUA HEALTH INC
Same official

Other billing entities under KIRBY, JOHN

Full network →
ProviderLocationPaid
Preffered Diognostic ImageingBellflower, CA$22K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.